Selecting strong buy biotech stocks isn’t easy when most of them don’t make money. Here are three possibilities to meet this challenge. More
Articles
Avoid Salesforce Stock: CRM’s Shocking Revenue Miss Signals Trouble Ahead
Down 6% on the year, Salesforce remains a troubled stock that investors should avoid for the time being. More
7 Dividend Stock Dynamos to Upgrade Your Income Game
While you can swing for a high-leverage growth idea, why not consider high dividend stocks to put a run or two on the board? More
3 Augmented Reality Stocks That Could Make Your Grandchildren Rich
These augmented reality stocks are positioned to provide substantial returns to investors due to their significant growth potential. More
FDX Stock Earnings: FedEx Beats EPS, Beats Revenue for Q4 2024
FDX stock results show that FedEx beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. More
PRGS Stock Earnings: Progress Software Beats EPS, Beats Revenue for Q2 2024
PRGS stock results show that Progress Software beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More